Anthropic company has unveiled a new artificial intelligence model called Claude for Life Sciences. This new tool is designed for researchers and allows them to use entropic artificial intelligence technology to advance scientific discoveries.
According to CNBC, Anthropic says Claude for Life Sciences is built on the company’s existing artificial intelligence models, but supports integration with common scientific tools in laboratories during research and development.
The Claude for Life Sciences model is designed for scientific discoveries
This new system can help researchers at all stages of the scientific discovery process, from reviewing scientific sources and working on hypotheses to analyzing data, writing documentation for regulatory bodies, and more.
The launch of Claude for Life Sciences is Entropy’s first major step into life sciences and comes just months after the company hired Eric Kaderer-Abrams, a veteran life sciences industry executive, as head of its biology and life sciences division.
“We’re at the point now where we’ve decided to pursue this area as a major investment area,” Kaderer-Abrams said in an interview after being hired by Entropic. “We want a significant percentage of all life science activity in the world to be based on Claude, just like the role this technology plays in programming today.”
Kaderer-Abrams also said that researchers previously used entropic models to help separate parts of the scientific process, so the company decided to launch Claude for Life Sciences to support researchers from start to finish.
This means Entropic will have to forge close partnerships with key players in the life sciences ecosystem, including companies like PubMed and Benchling. The company has also announced that it is partnering with companies that can help life sciences organizations use artificial intelligence.
RCO NEWS




